Crossmark

Follistatin is a novel therapeutic target and biomarker in <scp>FLT</scp> 3/ <scp>ITD</scp> acute myeloid leukemia

Crossref DOI link: https://doi.org/10.15252/emmm.202012911

Published Online: 2020-08-07

Published Print: 2020-08-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

He, Bai‐Liang

Yang, Ning

Man, Cheuk Him

Ng, Nelson Ka‐Lam

Cher, Chae‐Yin

Leung, Ho‐Ching

Kan, Leo Lai‐Hok

Cheng, Bowie Yik‐Ling

Lam, Stephen Sze‐Yuen

Wang, Michelle Lu‐Lu

Zhang, Chun‐Xiao

Kwok, Hin

Cheng, Grace

Sharma, Rakesh

Ma, Alvin Chun‐Hang

So, Chi Wai Eric https://orcid.org/0000-0002-4117-0036
Kwong, Yok‐Lam

Leung, Anskar Yu‐Hung https://orcid.org/0000-0001-9975-8687
License Information

Version of Record valid from 2020-08-07
More Information

Publication History

Published: 2020-08-07